Why is Laurus Labs falling/rising?

As of 17-Sep, Laurus Labs Ltd is currently priced at 892.10, reflecting a decrease of 3.05, or 0.34%. The stock has been underperforming recently, having fallen for the last three days, resulting in a total decline of 0.44% during this period. Despite this short-term downturn, the stock has shown strong performance over the longer term, with a year-to-date increase of 48.10% and a remarkable 78.17% rise over the past year. However, the stock is currently 3.41% away from its 52-week high of Rs 922.55 and has seen a significant drop in investor participation, with delivery volume decreasing by 26.88% compared to the five-day average. While the company has demonstrated high management efficiency and impressive growth in net profit, the long-term growth outlook appears poor due to a modest operating profit growth rate of 7.84% over the past five years.
In the broader market context, Laurus Labs has underperformed the benchmark Sensex in the short term, with a weekly return of -0.32% compared to the Sensex's gain of 1.56%. This underperformance may be contributing to the stock's recent decline. Despite the company's strong fundamentals, including high institutional holdings and significant profit growth, the stock's valuation appears expensive relative to its historical averages, which could be causing some investor hesitation. The combination of falling investor participation and a recent streak of price declines suggests that market sentiment may be cautious, even in light of the company's positive long-term performance metrics.